FDA Updates Guidance On Avoiding Off-Label Promotion

By Jeff Overley (February 28, 2014, 6:35 PM EST) -- Aiming to erase confusion, the U.S. Food and Drug Administration on Friday updated its policies on how drugmakers and medical device manufacturers can distribute scientific studies about unapproved uses of their products without engaging in illicit off-label promotion....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Attached Documents

Related Sections

Law Firms


Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!